Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Bright Minds Biosciences Inc. (DRUG) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.93M |
|
-- |
|
-- |
|
$4.09M |
|
$-4.09M |
|
$1.15M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
$-4.09M |
|
$-4.07M |
|
6.88M |
|
6.88M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$60.27M |
|
-- |
|
$0.08M |
|
$60.35M |
|
$1.67M |
|
$0.03M |
|
$0.03M |
|
$1.70M |
|
$58.65M |
|
$58.65M |
|
$58.65M |
|
7.64M |
|
| Cash Flow Statement Financials | |
$-6.21M |
|
-- |
|
$61.17M |
|
$4.09M |
|
$59.27M |
|
$55.18M |
|
$2.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
36.10 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.00% |
|
-5.00% |
|
-4.86% |
|
-5.00% |
|
$7.68 |
|
$-0.90 |
|
$-0.90 |
|